Chugai Pharmaceutical Co Ltd (CHGCF)
37.18
-1.08
(-2.84%)
USD |
OTCM |
Oct 08, 16:00
Chugai Pharmaceutical Market Cap : 61.16B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 61.16B |
| October 07, 2026 | 62.95B |
| October 06, 2026 | 63.60B |
| October 05, 2026 | 64.64B |
| October 02, 2026 | 62.96B |
| October 01, 2026 | 62.26B |
| September 30, 2026 | 66.71B |
| September 29, 2026 | 65.14B |
| September 28, 2026 | 66.55B |
| September 25, 2026 | 68.30B |
| September 24, 2026 | 67.12B |
| September 23, 2026 | 70.04B |
| September 22, 2026 | 71.11B |
| September 21, 2026 | 71.33B |
| September 18, 2026 | 68.47B |
| September 17, 2026 | 70.04B |
| September 16, 2026 | 58.02B |
| September 15, 2026 | 67.75B |
| September 14, 2026 | 71.14B |
| September 11, 2026 | 70.34B |
| September 10, 2026 | 65.57B |
| September 09, 2026 | 68.07B |
| September 08, 2026 | 71.95B |
| September 04, 2026 | 71.31B |
| September 03, 2026 | 72.39B |
| Date | Value |
|---|---|
| September 02, 2026 | 68.44B |
| September 01, 2026 | 68.12B |
| August 31, 2026 | 72.82B |
| August 28, 2026 | 73.06B |
| August 27, 2026 | 72.04B |
| August 26, 2026 | 70.55B |
| August 25, 2026 | 69.78B |
| August 24, 2026 | 73.85B |
| August 21, 2026 | 69.15B |
| August 20, 2026 | 70.89B |
| August 19, 2026 | 70.46B |
| August 18, 2026 | 68.63B |
| August 17, 2026 | 73.70B |
| August 14, 2026 | 71.11B |
| August 13, 2026 | 71.71B |
| August 12, 2026 | 72.32B |
| August 11, 2026 | 70.83B |
| August 10, 2026 | 73.22B |
| August 07, 2026 | 70.56B |
| August 06, 2026 | 71.48B |
| August 05, 2026 | 68.05B |
| August 04, 2026 | 71.86B |
| August 03, 2026 | 69.58B |
| July 31, 2026 | 71.04B |
| July 30, 2026 | 76.62B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 59.18B |
| Daiichi Sankyo Co., Ltd. | 30.89B |
| Eisai Co., Ltd. | 8.346B |
| Santen Pharmaceutical Co., Ltd. | 3.421B |
| Ono Pharmaceutical Co., Ltd. | 6.640B |
Market Cap Related Metrics
| PE Ratio | 20.04 |
| PS Ratio | 7.031 |
| PEG Ratio | 1.296 |
| Price to Book Value | 4.902 |
| Price to Free Cash Flow | 26.14 |
| Price | 37.18 |
| Earnings Yield | 4.99% |
| PEGY Ratio | 1.050 |
| Operating PE Ratio | 13.93 |
| Normalized PE Ratio | 19.13 |